ArticleScientific reports2026
Deep learning-based automatic segmentation and classification for cervical cancer detection using an improved U-Net and ensemble methods.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is the fourth leading cause of cancer-related illness and death among women worldwide. The Pap test is a widely used screening technique to detect abnormal cells that can become cancerous. In this research, we proposed a method for automatic segmentation and classification of cervical cancer cell images. The method uses an improved U-Net architecture to segment the image and identify the region of interest (ROI). Following segmentation, we classify the cervical cell type using ResNet50V2 and an ensemble of different pretrained models to enhance performance. We developed several pipelines for cervical cancer detection, including a normal method, with and without RES_DCGAN, before classification and segmentation tasks. The proposed method was evaluated using the Pomeranian, Herlev, and SIPaKMeD datasets. The experimental results showed that whole-cell segmentation achieved 99.53%, 88.95%, and 98.3% accuracy when RES_DCGAN was added before the segmentation. The framework achieved 96% and 95% accuracy for multi-class classification on the Pomeranian and SIPaKMeD datasets, respectively. Additionally, the Herlev dataset scored an accuracy of 91%, while SIPaKMeD achieved 99% for the binary classification of cervical cell types using the ensemble method. In conclusion, the deep learning-based segmentation and classification method demonstrated promising results for cervical cancer detection and can help pathologists diagnose the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.